Abstract | PURPOSE: Knowledge of the role of chemokines in the inflammation during neuroborreliosis (NB) is limited. We evaluated the pre- and post-treatment concentration of CXCL8, CXCL10, CXCL11, CXCL12, and CXCL13 in serum (s) and cerebrospinal fluid (csf) in patients with NB. RESULTS: There was a statistically significant increase in pre-treatment s CXCL8, CXCL10, CXCL11, CXCL12, CXCL13 and csf CXCL8, CXCL11, CXCL12, CXCL13 in patients with early form of NB. CXCL8, CXCL11, CXCL12 and CXCL13 increase was the highest in csf. After treatment, a significant decrease in csf chemokine levels (except CXCL10) and s levels (except CXCL11) was observed. CONCLUSIONS: CXCL8, CXCL10, CXCL11, CXCL12, CXCL13 are involved in the pathomechanism of NB but their role is different in s and csf. CXCL13 seems to be a good biomarker for NB. In early NB, it may facilitate the diagnosis and monitoring of therapy. However tick-borne encephalitis needs to be excluded as it also increases chemokine concentration. Decrease in all examined chemokines in s and csf after treatment suggests that chemokines may be useful in monitoring response to NB therapy.
|
Authors | Anna Moniuszko, Piotr Czupryna, Sławomir Pancewicz, Krzysztof Rutkowski, Olga Zajkowska, Renata Swierzbińska, Sambor Grygorczuk, Maciej Kondrusik, Piotr Owłasiuk, Joanna Zajkowska |
Journal | Immunology letters
(Immunol Lett)
2014 Jan-Feb
Vol. 157
Issue 1-2
Pg. 45-50
ISSN: 1879-0542 [Electronic] Netherlands |
PMID | 24239846
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Chemokine CXCL10
- Chemokine CXCL11
- Chemokine CXCL12
- Chemokine CXCL13
- Chemokines, CXC
- Interleukin-8
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Chemokine CXCL10
- Chemokine CXCL11
- Chemokine CXCL12
- Chemokine CXCL13
- Chemokines, CXC
(blood, cerebrospinal fluid)
- Female
- Humans
- Interleukin-8
- Lyme Neuroborreliosis
(blood, cerebrospinal fluid)
- Male
- Middle Aged
- ROC Curve
- Reference Values
|